Coronary heart disease (CHD) is a leading cause of morbidity and mortality globally. Hypercholesterolemia is one of the major risk factors for CHD. With the increase in aging populations and ...

No writing assistance was utilized in the production of this manuscript. Homozygous familial hypercholesterolemia is a rare but significant cause of early-onset coronary heart disease. Early ...

Alnylam Pharmaceuticals ALNY announced that it has submitted a Type II Variation to the European Medicines Agency for ...

The genetic condition increases the risk of heart disease by 20-fold. The Ministry of Health (MOH) is set to introduce a ...

Familial Hypercholesterolemia is a genetic disorder characterized by abnormally high levels of low-density lipoprotein (LDL) cholesterol in the blood, a significant modifiable risk factor for ...

The new scientific statement has highlighted the often underused role of lipoprotein apheresis as a therapeutic option for ...

Considering taking supplements to treat familial hypercholesterolemia? Below is a list of common natural remedies used to treat or reduce the symptoms of familial hypercholesterolemia. Follow the ...

The biotech industry offers a compelling investment opportunity due to its potential for disruptive innovations and high ...

Knowles J, Ouellette T. Family Heart Foundation progress report: familial hypercholesterolemia in America. 2024 Family Heart Global Summit. Presented September 22, 2024. https://familyheart.org ...

A childs heart health is profoundly influenced by the health and habits of their parents beyond just their own lifestyle ...

Immunovant, Inc. shifts focus to anti-FcRn antibody IMVT-1402, but high R&D costs and uncertainty warrant caution for ...